Krystal Biotech, Inc. (KRYS) — Revenue

Annual figures by fiscal year, from SEC filings.

2021: $02022: $02023: $50.70M2024: $290.51M2025: $389.13M$389.13M
2021Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$389.13M+33.9%
2024$290.51M+473.0%
2023$50.70M
2022$0
2021$0